Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Priaculin
- Development stage
- Unknown
- Lead developer
- Schwabe
- Modality
- Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Priaculin (WS 5550) is a standardized botanical extract derived from *Sideritis scardica* (commonly known as Greek Mountain Tea), developed by Dr. Willmar Schwabe GmbH & Co. KG. It is primarily being investigated for the treatment of cognitive impairment and potentially other central nervous system (CNS) disorders such as depression. The pharmacological profile of Priaculin is characterized by its action as a triple monoamine reuptake inhibitor, meaning it inhibits the reuptake of serotonin, norepinephrine, and dopamine. This mechanism is intended to enhance neurotransmitter levels in the synaptic cleft, thereby improving cognitive function and mood. Clinical development has progressed through Phase I safety and pharmacokinetic studies, including single and multiple ascending dose trials in healthy volunteers.
- Other names
- Sideritis scardica extract
02
Targets
SERT (Sodium-dependent serotonin transporter)DAT (Dopamine plasma membrane transport protein)NET (Norepinephrine Transporter)
Beyond the preview
Go deeper on Priaculin.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Priaculin.